Satoshi Yamagiwa - Concepedia

Author

Satoshi Yamagiwa

Also Known As

Michio Senju, S YAMAGIWA, S Yamagiwa, S. Yamagiwa, SATOSHI YAMAGIWA, Satoshi YAMAGIWA, Satoshi Yamagiwa, Yamagiwa S, Yasushi Tamura

141

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Niigata University Niigata University Medical and Dental Hospital Juntendo University Shizuoka Hospital Fukushima Medical University Teikyo University

About

Satoshi Yamagiwa is an author at Niigata University specializing in medicine, pathology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.5K
2	Cell Biology	11	12	562
3	Health Sciences	4	4	97
4	Public Health	2	2	63
5	Allergy	1	1	46

Satoshi Yamagiwa

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
A Role for TGF-β in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood Satoshi Yamagiwa, J. Dixon Gray, Shigeo Hashimoto, The Journal of Immunology	2001	530
Generation Ex Vivo of TGF-β-Producing Regulatory T Cells from CD4+CD25− Precursors Song Guo Zheng, J. Dixon Gray, Kazuo Ohtsuka, The Journal of Immunology	2002	457
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population Minoru Nakamura, Nao Nishida, Minae Kawashima, The American Journal of Human Genetics Genome-wide Association StudyHepatologyLiver PhysiologyGeneticsGenetic Epidemiology	2012	269
Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. Kazunari Sato, Kazuo Ohtsuka, Keizo Hasegawa, The Journal of Experimental Medicine Cell TherapyT-regulatory CellImmunologySelf ReactivityImmunologic Mechanism	1995	195
Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma Xiu Hua Yang, Satoshi Yamagiwa, Takafumi Ichida, Journal of Hepatology LiverHepatologyLiver PhysiologyT-regulatory CellImmunology	2006	162
Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice Yusuke Watanabe, Atsunori Tsuchiya, Satoshi Seino, Stem Cells Translational Medicine	2018	152
Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence Hiroteru Kamimura, Satoshi Yamagiwa, Atsunori Tsuchiya, Journal of Hepatology Tumor BiologyNkg2d Ligand ExpressionEarly RecurrenceCancer ImmunosurveillanceHepatology	2011	116
Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis Akira Honda, Atsushi Tanaka, Tetsuji Kaneko, Hepatology GastroenterologyPrimary Biliary CirrhosisCholangiopathiesUdca+bf Combination TherapyBf Treatment	2019	111
<b>Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel </b><b>diseases </b> Kentaro Tominaga, Satoshi Yamagiwa, Toru Setsu, Biomedical Research	2017	65
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies Takamasa Kobayashi, Hirokazu Kawai, Oki Nakano, BMC Cancer	2018	60

Page 1